About Boundless Bio
Boundless Bio is a private company based in San Diego, California. It has reported $228,817,514 raised in three offerings on Form D since March 2020. Its chief executive is Zachary Hornby.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 5, 2023 | Aug 15, 2023 | $100,000,000fully sold | 26 | $3.8M | EquityRule 506(b) | Form D ↗ |
| Apr 23, 2021 | May 4, 2021 | $105,585,007fully sold | 28 | $3.7M | EquityRule 506(b) | Form D ↗ |
| Aug 24, 2018 | Mar 12, 2020 | $23,232,507of $52.5M target | 23 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $228,817,514 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Boundless Bio's Form D filed Aug 15, 2023.
ZH
Zachary Hornby
CEO, President, and Director
BD
Benjamin Cravatt, Ph.D.
Director
FD
Fabio Pucci, Ph.D.
Director
JD
Jakob Loven, Ph.D.
Director
JL
Jennifer Lew
Director
CD
Christine Brennan, Ph.D.
Director
JD
Jonathan Lim, M.D.
Director
KB
Earlier filings also listed Ho Cho, Ph.D. (director, last listed May 2021), Carolyn Ng, Ph.D. (director, last listed May 2021), Scott Moorefield, Ph.D. (director, last listed Mar 2020), Jason Christiansen, Ph.D. (director, last listed Mar 2020) and Chris Hassig, Ph.D. (director, last listed Mar 2020).